ZEISS is a technology enterprise that has operated at the forefront of optics and optoelectronics for over 175 years. The company generates nearly €12 billion in annual revenue and employs around 46,600 people across 50 countries, serving customers in semiconductors, healthcare, research, and industrial quality sectors.
The company's technical capabilities span semiconductor manufacturing technology, research microscopy, medical devices for ophthalmology and microsurgery, industrial quality solutions, and emerging fields such as extended reality. Its semiconductor offerings enable microchip production, while its medical technology supports healthcare professionals in surgical procedures and vision care. Research microscopy products allow scientists to visualize microscopic structures, and industrial quality solutions help manufacturers maintain efficiency and precision.
ZEISS invests 15% of its annual revenue directly into research and development, reflecting its commitment to innovation across its portfolio. The company is wholly owned by the Carl Zeiss Foundation and is working toward carbon neutrality by 2024-25 as part of its broader focus on sustainable development. Its work addresses challenges in healthcare, digitalization, energy, and sustainability.
